Remdesivir against COVID-19 and other viral diseases
JJ Malin, I Suárez, V Priesner… - Clinical microbiology …, 2020 - Am Soc Microbiol
Patients and physicians worldwide are facing tremendous health care hazards that are
caused by the ongoing severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) …
caused by the ongoing severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) …
A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
…, G Fätkenheuer, J Rybniker, JJ Malin - EMBO molecular …, 2021 - embopress.org
The ongoing SARS‐CoV‐2 pandemic stresses the need for effective antiviral drugs that can
quickly be applied in order to reduce morbidity, mortality, and ideally viral transmission. By …
quickly be applied in order to reduce morbidity, mortality, and ideally viral transmission. By …
SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19
…, Z McQuilten, CD Spinner, JJ Malin… - Cochrane Database …, 2022 - cochranelibrary.com
Background Monoclonal antibodies (mAbs) are laboratory‐produced molecules derived
from the B cells of an infected host. They are being investigated as potential prophylaxis to …
from the B cells of an infected host. They are being investigated as potential prophylaxis to …
[HTML][HTML] Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study
…, N Taback, HA Huskamp, JL Malin… - Journal of clinical …, 2012 - ncbi.nlm.nih.gov
Purpose National guidelines recommend that discussions about end-of-life (EOL) care
planning happen early for patients with incurable cancer. We do not know whether earlier EOL …
planning happen early for patients with incurable cancer. We do not know whether earlier EOL …
Changes of cortical motor area size during immobilization
J Liepert, M Tegenthoff, JP Malin - Electroencephalography and clinical …, 1995 - Elsevier
Changes of motor cortex organization after lesions in the nervous system can be demonstrated
by mapping the motor cortex with transcranial magnetic stimulation. We studied cortical …
by mapping the motor cortex with transcranial magnetic stimulation. We studied cortical …
End-of-life care discussions among patients with advanced cancer: a cohort study
…, HA Huskamp, NL Keating, JL Malin… - Annals of internal …, 2012 - acpjournals.org
Background: National guidelines recommend that physicians discuss end-of-life (EOL) care
planning with patients with cancer whose life expectancy is less than 1 year. Objective: To …
planning with patients with cancer whose life expectancy is less than 1 year. Objective: To …
The glutamate antagonist riluzole suppresses intracortical facilitation
…, P Schwenkreis, M Tegenthoff, JP Malin - Journal of neural …, 1997 - Springer
The effect of the glutamate antagonist riluzole on excitatory and inhibitory phenomena in the
human motor system was studied by transcranial magnetic stimulation (TMS) and …
human motor system was studied by transcranial magnetic stimulation (TMS) and …
[PDF][PDF] Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States
JL Malin, EC Schneider, AM Epstein, J Adams… - J Clin …, 2006 - researchgate.net
… Malin JL, Kahn KL, Adams J, et al: Validity of cancer registry data for measuring the quality of
breast cancer care. J Natl Cancer Inst 94:835-844, 2002 26. White … We also acknowledge …
breast cancer care. J Natl Cancer Inst 94:835-844, 2002 26. White … We also acknowledge …
Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use
KL Kahn, EC Schneider, JL Malin, JL Adams… - Medical care, 2007 - journals.lww.com
Background: Among breast cancer patients, tamoxifen use is associated with reduced risk of
disease relapse and death, but it is often difficult for women to sustain therapy during the 5 …
disease relapse and death, but it is often difficult for women to sustain therapy during the 5 …
Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19
Innate immunity triggers responsible for viral control or hyperinflammation in COVID‐19 are
largely unknown. Here we show that the SARS‐CoV‐2 spike protein (S‐protein) primes …
largely unknown. Here we show that the SARS‐CoV‐2 spike protein (S‐protein) primes …